A larger territory does not guarantee more sales: it can also create duplicate appointments, unpaid invoices, near-expiry stock, and weak product traceability. You will be able to select the right channel partner, test territory readiness, document commercial terms, and monitor expansion with measurable operating controls.
Key takeaways
- Ask for the distributor’s wholesale drug licence copy.
- Define territory, customer accounts, targets, and payment terms in writing.
- Check storage temperatures, batch records, expiry controls, and product returns.
- Compare sales, stock movement, expiry, and collections before expanding coverage.
What a Reliable PCD Pharma Distributor Actually Does
A reliable PCD pharma distributor does more than move cartons. It holds the applicable wholesale drug licence, buys through documented invoices, stores medicines correctly, supplies defined accounts, and preserves batch-level traceability from manufacturer to pharmacy or stockist. PCD franchise is a commercial arrangement, not a separate drug-licensing category.
| Role | Primary job | What it does not prove |
|---|---|---|
| Manufacturer | Makes and releases medicines under manufacturing controls | It will manage your territory or last-mile deliveries |
| Carrying-and-forwarding agent (C&F agent) | Holds and dispatches the manufacturer’s stock, often on its behalf | It is your independent market-building distributor |
| Wholesaler or stockist | Buys and resells licensed products to trade customers | It will develop a franchise territory |
| PCD pharma distributor | Builds demand and supplies an agreed territory under written terms | “Exclusive” has meaning without territory and performance conditions |
Before appointment, check for:
- A valid Form 20-B licence for drugs outside Schedules C, C(1) and X; Form 21-B for Schedule C and C(1); and Form 20-G for Schedule X where applicable.
- GST registration, a declared storage address, clean racks, pest control records, and calibrated temperature devices.
- Temperature mapping for storage areas and vehicles, excursion procedures, and a qualified person who decides whether affected stock can be sold.
- Batch records, an injectable-damage and recall process, and prompt escalation of quality complaints or suspected adverse drug reactions to the manufacturer’s quality or pharmacovigilance team.
- Separate Schedule H1 sale records containing prescriber, patient, drug and quantity details, retained for three years from the last entry.
Build the Territory Before You Appoint the Partner
Choose a territory only after measuring prescriber demand, pharmacy coverage, and existing channel rights; a large population alone does not prove a viable launch.
Territory selection should combine prescription potential with serviceability. Use prescriber mapping to identify clinics, hospitals, specialties, and monthly prescription opportunities, then use pharmacy mapping to confirm which outlets stock competing brands, accept new suppliers, and can pay on agreed terms.
| Area | Evidence to check | Decision |
|---|---|---|
| Unserved cluster | Enough relevant prescribers, pharmacies, and delivery access | Pilot the area |
| Existing partner overlap | Same products, channels, or named towns already assigned | Redraw the boundary or obtain written consent |
| Demand without service | Regular prescriptions but poor stock availability | Appoint a capable local partner |
| Weak demand | Few prescribers, low pharmacy movement, high delivery cost | Reject the territory |
Launch with a defined town, district, product list, target, review date, and non-overlapping channels. Do not rely on the word “exclusive”; write the geographic boundary, online-sales rights, minimum purchases, expiry returns, and termination conditions into the agreement.
Before sub-distributor appointment, verify licences, storage, delivery routes, payment discipline, and downstream records. This matters for Schedule H1 products, which require a separate sale register retained for three years from the last entry.
Set FEFO dispatch, batch traceability, recall blocking, and injectable complaint escalation before the first shipment. Confirm whether supplements fall under the Food Safety and Standards Authority of India framework, and check DPCO price ceilings for scheduled formulations before setting trade terms.
Complete Distributor Due Diligence and Write the Deal Clearly
A first order should follow document checks, not a handshake. “PCD pharma franchise” describes a commercial arrangement, not a separate drug-licensing category, so the distributor must hold the wholesale licence required for the medicines it will buy, store and sell.
1. Complete drug licence verification: record the licence number, validity date, legal name, storage address and competent person. Check Form 20-B for drugs outside Schedules C, C(1) and X, Form 21-B for Schedule C and C(1) drugs, and Form 20-G for Schedule X drugs. Injectables can require more than Form 20-B.
2. Match the licence to the premises. Confirm at least 10 square metres for wholesale-only operations, or 15 square metres where retail and wholesale activities share the site. Inspect refrigeration, temperature logs, backup power and delivery equipment for products requiring cold storage.
3. Collect the GST registration, bank details, ownership or authorisation proof, two market references, payment history and delivery-route details. Confirm that the named competent person is actually available; a salesperson does not replace that requirement.
4. Put the order terms in writing: product composition and strength, batch and expiry details, invoice and tax treatment, approved prices, damaged-stock claims, short-dated-stock thresholds, returns, credit-note timing, freight and destruction records. For scheduled formulations, check the DPCO price ceiling, taxes and permitted trade margins.
5. If the distributor handles Schedule H1 medicines, verify downstream sale registers capture prescriber, patient, drug and quantity details and retain entries for three years from the last entry. The agreement must also prohibit stocking or selling expired medicines.
kelps healthcare can use this same file to approve a partner before releasing prescription products, rather than treating territory enthusiasm as evidence of compliance.
Control Quality, Cold Chain, Expiry, and Traceability After Appointment
Make every dispatch reconstructable from invoice to end customer. Your distributor’s system must support batch traceability, show expiry dates, quarantine suspect stock, and block further dispatch when a recall starts.
- Use FEFO inventory: release the batch with the earliest expiry first, not merely the batch received first.
- Record batch number, quantity, invoice, destination, and dispatch date for every movement.
- Keep damaged, recalled, and suspect units physically separated from saleable stock.
- Require prompt forwarding of product-quality complaints and suspected adverse drug reactions to the manufacturer’s quality or pharmacovigilance function.
Injectables need tighter handling than ordinary tablets. Check seals, ampoules, vials, and outer cartons for damage, and define who decides whether affected units can be released.
A cold-chain capability is credible only when storage rooms and vehicles have calibrated temperature devices, documented temperature mapping, and a written excursion procedure. A delivery reading alone does not prove that the shipment stayed within range; a qualified person must decide whether to release, quarantine, or reject it.
Put expiry controls in the agreement. Specify the near-expiry threshold, return eligibility, credit-note deadline, freight responsibility, and documented destruction route. Expired medicines must never be sold or kept for sale.
For Schedule H1 products, verify that each downstream stockist maintains a separate Schedule H1 register recording:
- Prescriber and patient details
- Drug name and quantity
- Sale date and prescriber information
Retain those records for three years from the last entry, and confirm the distributor holds the licence category required for the products, including Form 21-B for Schedule C and C(1) medicines.
Compare Network Performance Before Adding More Distributors
Compare distributors on territory-normalised performance, not invoice value. A large partner can bill more because it covers more outlets, while several territory-level partners can create stronger pharmacy reach with less concentration risk. Use the same 90-day period, product mix, credit terms, and territory potential for each comparison.
| Option | Advantages | Risks | Choose it when |
|---|---|---|---|
| One large partner | Lower coordination cost, unified stock control, wider delivery infrastructure | Dependence on one account, slower local feedback, weaker attention to small territories | Its service levels remain strong across all target districts |
| Several territory-level partners | Local relationships, faster market learning, less dependence on one account | More reconciliation, uneven execution, channel conflict | Territories differ sharply in demand, access, or payment behaviour |
Calculate order fill rate as the share of order lines delivered complete and on time. Compare secondary sales to pharmacies, collection days from invoice to payment, and expiry loss as expired or returned stock against purchases using the same formula for every partner. Strong primary billing with weak secondary sales signals channel loading, not demand.
Choose one large partner when it maintains reliable service across the full area and gives you usable outlet-level data. Choose several partners when one account leaves districts uncovered or delays collections. Before granting “exclusive” status, define the territory, sales channels, minimum purchases, online-sales rights, sub-distributor rules, expiry returns, and termination triggers in writing.
Frequently asked questions
What does a reliable PCD pharma distributor do?
A reliable distributor holds the required wholesale drug licence, buys against documented invoices, stores medicines correctly, serves defined accounts, and maintains batch-level traceability.
What should you check before appointing a PCD pharma distributor?
Check the licence copy, warehouse and storage conditions, delivery coverage, customer network, financial controls, product-handling process, and references. Write territory, targets, payment terms, and responsibilities into the agreement.
How do you control quality after appointing a distributor?
Review batch records, invoices, storage temperatures, expiry dates, transport conditions, returns, and complaints. For products requiring refrigeration, record temperatures across storage and delivery.
When should you add another medicine distributor?
Compare territory sales, active accounts, stock movement, expiry losses, collections, service levels, and unmet demand. Add coverage when performance data shows a defined gap rather than overlapping an existing network.
